(Q34272048)

1 August 2017

1 reference

title

Targeted therapy for malignant melanoma. (English)

1 reference

1 August 2017

Brown CK

1

1 reference

1 August 2017

Kirkwood JM

series ordinal

2

1 reference

1 August 2017

publication date

1 July 2001

1 reference

1 August 2017

published in

Current Oncology Reports

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

344-352

1 reference

Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma

1 August 2017

cites work

1 reference

12 December 2020

Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics

1 reference

12 December 2020

Molecular classification of cutaneous malignant melanoma by gene expression profiling

1 reference

12 December 2020

Association of EGFR gene fragments with nuclear matrix proteins in high and low metastatic melanoma cell lines

1 reference

12 December 2020

Immunotoxins directed against the high-molecular-weight melanoma-associated antigen. Identification of potent antibody-toxin combinations

1 reference

12 December 2020

Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.

1 reference

12 December 2020

Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization

1 reference

12 December 2020

Suppression of the malignant phenotype of melanoma cells by anti-oncogene ribozymes

1 reference

12 December 2020

T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy

1 reference

12 December 2020

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

12 December 2020

Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents

1 reference

12 December 2020

Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors

1 reference

12 December 2020

In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells

1 reference

12 December 2020

Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors

1 reference

12 December 2020

Induction of antitumor immunity after cure of pulmonary metastases, using staphylococcal enterotoxin B and bispecific antibody

1 reference

12 December 2020

Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins.

1 reference

12 December 2020

Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites

1 reference

12 December 2020

Therapeutic RNA and DNA enzymes

1 reference

12 December 2020

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

1 reference

12 December 2020

Long-term growth suppression of human glioma xenografts by chemoimmunoconjugates of 4-desacetylvinblastine-3-carboxyhydrazide and monoclonal antibody 9.2.27.

1 reference

12 December 2020

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

1 reference

12 December 2020

Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood

1 reference

12 December 2020

Potent and selective inhibition of gene expression by an antisense heptanucleotide

1 reference

12 December 2020

Targeted alpha therapy: evidence for potential efficacy of alpha-immunoconjugates in the management of micrometastatic cancer

1 reference

12 December 2020

gamma-L-Glutaminyl-4-hydroxybenzene, an inducer of cryptobiosis in Agaricus bisporus and a source of specific metabolic inhibitors for melanogenic cells

1 reference

12 December 2020

Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates

1 reference

12 December 2020

Adoptive immunotherapy involving recombinant human M-CSF and R24 anti-melanoma antibody induces human T-cell infiltration into human melanoma xenografts

1 reference

12 December 2020

A phase I/II dose-escalation study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for metastatic melanoma. Study Group on Gene Therapy of Metastatic Melanoma

1 reference

12 December 2020

Kinetics of cellular trafficking and cytotoxicity of 9.2.27-gelonin immunotoxins targeted against the high-molecular-weight melanoma-associated antigen

1 reference

12 December 2020

Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs

1 reference

12 December 2020

The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy

1 reference

12 December 2020

Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo.

1 reference

12 December 2020

In vitro splicing of the ribosomal RNA precursor of Tetrahymena: involvement of a guanosine nucleotide in the excision of the intervening sequence

1 reference

12 December 2020

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

1 reference

12 December 2020

Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage.

1 reference

12 December 2020

In vitro and in vivo targeting of gene expression to melanoma cells

1 reference

12 December 2020

c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice

1 reference

12 December 2020

Individually specified drug immunoconjugates in cancer treatment

1 reference

12 December 2020

Immunocytokines: a new approach to immunotherapy of melanoma.

1 reference

12 December 2020

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

12 December 2020

Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells

1 reference

12 December 2020

Interleukin-2: inception, impact, and implications

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro

1 reference

12 December 2020

Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral

1 reference

12 December 2020

Vaccine therapy for malignant melanoma

1 reference

12 December 2020

Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

10.1007/S11912-001-0088-2

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1042289045

0 references

Fatcat ID

release_w6avn3ggc5auxbp65sm3s5cmbi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w6avn3ggc5auxbp65sm3s5cmbi

24 November 2022

mapped directly with Wikidata item

1 reference